Cryopreservation of Ovarian Tissue

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT01558544
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Fertility Preservation
  • Risk of Premature Ovarian Failure

Eligibility Criteria

Sex
FEMALE
Age
N/A - 45 Years
Healthy Volunteers
Not accepted

Interventions

  • surgery to remove ovaries or high dose chemotherapy — PROCEDURE
    oophorectomy to remove a disease ovary.

Study Details

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Key Dates

Start date
Apr 30, 1997
Status verified
Oct 2025
Primary completion
Oct 31, 2029
Completion
Oct 31, 2029

Study Design

Enrollment
300 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Use of high dose chemotherapy
    Use of chemotherapy without removal of the disease ovary.

Primary Outcome Measure

CRYOPRESERVATION OF OVARIAN TISSUE FOR POTENTIAL IN VITRO MATURATION OR AUTOLOGOUS TRANSPLANTATION [ Time Frame: 6 months to a year post surgery, hormone testing will be performed to test ovarian function. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ronald O. Perelman and Claudia Cohen Center for Reproductive MedicineNew YorkNew York10021
Rodriq Stubbs, NP
[email protected]
646-962-3276
Mitasha C. Joseph, RN, MPA
[email protected]
646-962-3382
Glenn Schattman, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine· New York, NY

Related Studies